Introduction
The human gene encoding the small GTP-binding protein Krev-1/rap1a was isolated by Pizon et al. in 1988 based on extensive sequence conservation with the Drosophila Ras gene (Pizon et al., 1988) and by Kitayama et al. in 1989 based on its ability to revert cells transformed by the oncoprotein Ras to a normal cell morphology (Kitayama et al., 1989) . Because of the sequence conservation and the reversion phenotype, Krev-1 was initially hypothesized to function antioncogenically as a negative eector competing with Ras for downstream targets important for control of cell signaling and cell morphology. This hypothesis was supported by the discovery that Krev-1 could bind tightly to a number of Ras eectors, including Ras GTPase-activating protein (GAP) (Frech et al., 1990) , the oncogene Ras (Nassar et al., 1995; Zhang et al., 1993) and Ral-GEF , as it seemed likely that Krev-1 might act to sequester these proteins from Ras. However, a number of subsequent studies performed to characterize the antioncogenic function of Krev-1 (Buss et al., 1991; Jelinek and Hassell, 1992; Sakoda et al., 1992; Sato et al., 1994; Wojtaszek et al., 1993) have failed to con®rm more than a very weak anti-oncogenic activity, initially leaving its role as a regulator of Ras in question.
Adding an additional dimension to the understanding of Krev-1 function, it has also been shown to be a component of a large complex with cytochrome b of human neutrophils (Quinn et al., 1989 (Quinn et al., , 1992 . Cytochrome b 558 is a component of the NADPH oxidase which is responsible for producing à`r espiratory burst'' of free radicals that degrade foreign objects: other components of the oxidase include p47phox and p67phox, and the small GTPbinding protein Rac (reviewed in Bokoch, 1995; Bokoch and Knaus, 1994) . Studies indicating Krev-1 helps activate NADPH oxidase (Eklund et al., 1991; Maly et al., 1994) are particularly provocative given recent demonstration that Ras signaling proceeds in part through inducing superoxide production by activation of the NADPH oxidase (Irani et al., 1997) , as control of cellular superoxide levels may provide a novel mechanism by which Krev-1 regulates cell transformation by Ras.
Further insights into potential Krev-1 activities derive from studies of homologs of the protein in lower eukaryotes. Dominant gain-of-function mutants of the Drosophila Ras3 gene (Pizon et al., 1988) , a gene 88% identical to human Krev-1, result in a development defect of altered cell fate in differentiation of the ommatidia composing the eye (Hariharan et al., 1991) . The yeast gene RSR1/BUD1 (57% identity to KRev-1) (Ruggieri et al., 1992) was ®rst identi®ed in S. cerevisiae as a multicopy suppressor of a cdc24 mutation which causes lethality due to inability to bud (Bender and Pringle, 1989) . A series of genetic studies initally implicated both RSR1/BUD1 and Krev-1 as controlling agents for cell polarity Ruggieri et al., 1992) . In subsequent work, a number of studies have addressed the interaction of RSR1 with signal transduction pathways relevant to cytoskeletal controls. In yeast, these studies have begun to establish connections between RSR1 with speci®c GEF and GAP proteins (Bender, 1993; Park et al., 1993; Powers et al., 1991) ; and with CDC24 and Rho-class GTPases including Cdc42 (Zheng et al., 1995) , implying cross-signaling to MAP kinase cascades involved in dierentiation control (Simon et al., 1995; Zhao et al., 1995) and regulation of actin-based processes in mammals (Coso et al., 1995; Nobes and Hall, 1995) . Finally, the tuberous sclerosis-2 (TSC2) product, tuberin, has been shown to possess GAP activity for Krev-1, linking Krev-1 to the growth derangement accompanying development of tuberous sclerosis (Wienecke et al., 1995) . Together, this wide array of studies suggest a very complex Krev-1 function related to cell morphol-ogy and cell polarity, while emphasizing that much remains to be clari®ed.
We have been utilizing the S. cerevisiae budding pathway in a variety of screening strategies to elucidate cell growth controls in mammals (Khazak et al., 1995; Law et al., 1996) . As part of this approach, and because of the intrinsic interest of Krev-1 biology, we used this gene as the bait in a two-hybrid screen to identify partner proteins which might yield clues as to its function. As a result of this screen, we here report the isolation and preliminary characterization of KRIT1, a novel gene whose protein product interacts strongly and speci®cally with Krev-1, and which maps to human chromosome 7q21-22, a region proposed to encompass an antioncogene.
Results and discussion

Cloning of Krit1
We used LexA-fused Krev-1 in an interaction trap/two hybrid approach Gyuris et al., 1993) to screen a HeLa cDNA library to identify novel partner proteins. From a screen of >500 000 transformants, we isolated 8 clones which were positive after puri®cation of plasmid and retransformation into naive yeast containing LexA-Krev-1. Of the eight, one interacted with intermediate anity as assayed by twohybrid, and proved to be a partial cDNA for the oncoprotein Raf, initiating at amino acid 56, at the approximate beginning of the Ras binding domain or RBD (Nassar et al., 1995) . Since Raf has been described as interacting with Krev-1, isolation of this cDNA indicated that the LexA-Krev1`bait' was folded appropriately to allow physiological interactions.
The other seven clones emerging from the screen appeared to interact very strongly with Krev-1, and when sequenced proved to be multiple independent isolates of the cDNA encoding a novel protein which we have designated Krit1 (for Krev-1 Interaction Trapped 1). This cDNA lacked a suitable candidate methionine for initiation of translation, and was therefore presumed to be a partial cDNA. 5'-RACE was used with human kidney cDNA to extend the Krit1 clone, resulting in the addition of 398 base pairs of novel sequence. The assembled cDNA comprised 1986 base pairs (bp) with an additional 18 bp poly-A tail. A methionine codon located 26 bp from the 5' end of the assembled sequence initiates the translation of a 529 amino acid open reading frame (ORF), followed by * 370 bp of 3' untranslated sequence containing an Alu repeat family member ( Figure 1a ). Repeated eorts at 5' RACE did not result in the isolation of additional upstream sequence; and of multiple expressed sequence tags (EST) corresponding to Krit1 in the dbEST or TIGR databases, all commence comparably to or 3' of the assembled Krit1 clone. The Krit1 cDNA sequence has been deposited in Genbank (accession number U90268).
The Krit1 cDNA was used as a probe to screen a human genomic gt11 library. This screen resulted in the isolation of a 9.1 kb insert encompassing the 5' end of the Krit1 cDNA ( Figure 1b) . Analysis of the sequence of this clone led to the identi®cation of three exons of the Krit1 cDNA (bp 1 ± 136, 137 ± 250 and 251 ± 396), and demonstrated the presence of an in-frame stop codon 251 bp upstream of the assigned ATG for initiation of protein translation, with no intervening splice sites. Use of the program TSSW to scan the 1.2 kb of sequence¯anking the cDNA start site indicated a number of potential promoter elements, including a preferred TATAAAA site for initiation of transcription 731 bp upstream of the endpoint of the cDNA (757 bp upstream of the ATG) and additional clustered binding sites for transcription factors. An additional potential TATAAAA is identi®ed at 228 bp upstream of the cDNA endpoint (254 upstream of the ATG). Sequence for this genomic clone has similarly been deposited to Genbank (accession number U90269).
Krit1 protein structural features
Inspection of the Krit1 predicted protein sequence revealed several features of note. The 529 amino acid sequence has a predicted molecular weight of 60.8 kD (re¯ecting the presence of a large percentage of aromatic residues, particularly tyrosines), and a calculated pl of 7.9. The Krit1 protein sequence possesses a number of regions predicted to be hydrophobic, particularly at the carboxy-terminal end of the protein; a single transmembrane domain is predicted at aa 339 ± 359 (Hofmann and Stoel, 1993) .
Krit1 is not strongly homologous to any previously described protein. However, comparison of the Krit1 protein sequence of Genbank by BLAST (Altschul et al., 1990 ) indicated a potential relation to two groups of proteins. The carboxy-terminal region of Krit 1 (aa *280 ± 433), originally isolated as interacting with Krev-1, may be weakly related to a family of cytoskeletal and membrane-associated proteins de®ned by erythrocyte protein 4.1 (Conboy et al., 1986) , including among other moesin, azrin, and merlin (Trofatter et al., 1993) . This assignment is not certain, since the use of additional homology prediction algorithms that incorporate structural information (including Prosite, Blocksearch, and 3-D threading (Moult, 1996) ) indicates that particular residues thought to be characterisitic of the Band 4.1 protein family are not well conserved in Krit1, despite the general homology of the region (Figure 2a ). In contrast, the amino-terminal end of Krit 1 (aa *83 ± 215) contain 4 ankyrin repeats with unambiguous match to previously de®ned consensus sequence (Bork, 1993) (Figure 2b ). Ankyrin motifs have been shown to be interactive domains, and these may mediate association of Krit-1 with additional cellular partners. While multiple classes of proteins possess ankyrin repeats, they are extremely abundant in cytoskeletal and membrane attached proteins. In conjunction with the hydrophobic character and predicted transmembrane domain for Krit1 and the known localization of Krev-1 to endosomal compartments (Beranger et al., 1991; Pizon et al., 1994) , the presence of multiple ankyrin repeats suggests that Krit1 might similarly be associated with intracellular membranes.
Speci®city of Krit1 interaction with Krev-1
All proteins de®ned to date as interacting with Krev-1 also interact to some degree with Ras. To investigate the and Brent, 1994) in which we tested for association with 25 distinct proteins similarly fused to LexA (see Materials and methods). When so tested, Krit1 interacted strongly with Krev-1, very weakly with Ras, and not at all with any non-speci®c proteins, supporting the idea that this protein is a speci®c partner for Krev-1. We then quantitated the interaction of full length Krit1 (Krit1 1 ± 529 ) with Krev-1 and Ras (Table 1) . Krit1 1 ± 529 associated strongly with Krev-1: approximately 232 bgalactosidase units and very strong growth on medium lacking leucine, as compared to 2 b-galactosidase units and weak growth on leucine-minus medium for Krit1 1-529 with Ras. In contrast, similarly expressed Raf, used as a control, interacted weakly with Krev-1 (5 b-galactosidase units and moderate growth on leucine-minus medium) but very strongly with Ras (638 b-galactosidase units and very strong growth on leucine-medium).
To more exactly de®ne the domain of Krit1 required for interaction with Krev-1, we compared the ability of a series of truncated derivatives of Krit1 to interact with Krev-1 (Figure 3 , Table 1 ). The isolated aminoterminal domain of the Krit1 protein (Krit1 1 ± 303 ), containing the intact ankyrin repeat motif, completely failed to interact with Krev-1. As noted above, Krit1 126-530 associated with Krev-1 as well as full length Krit1, again implying that interaction is speci®ed in the carboxy-terminal region of the protein. Finally, a short deletion of the carboxy-terminal end of the Krit1 protein (aa 483 ± 529) resulted in near-total loss of protein interaction, while substitution of two missense mutations at aa 368 and 393 caused some diminishment of interaction (91 versus 232 2 b-galactosidase). All Krit1 derived proteins were con®rmed to be expressed to similar levels by Western analysis (not shown) and neither Krit1 nor Raf interacted with the LexA-bicoid negative control.
Cumulatively, these results indicate that Krit1 interacts preferentially with Krev-1, while Raf interacts preferentially with Ras. The carboxy-terminal region of Krit1 is necessary and sucient to mediate interaction with Krev-1, while the amino-terminal ankyrin repeat containing region may be utilized for association with additional cellular proteins.
Krit1 expression properties
To assess the expression pattern of the Krit1 transcript, 32 P-labeled cDNA spanning the Krit1 coding region but excluding the carboxy-terminal Alu sequence was used to probe a multiple tissue Northern blot (MTN1, Clontech). Weak cross-hybridizing signals were observed in heart, muscle, and brain, but not in other tissues including lung, liver, kidney and placenta. A single hybridizing species of *3.5 kb was observed in brain, which was the most intense individual signal obtained. Multiple cross-hybridizing species in the 3.0 ± 4.5 kb size range, including at least three distinct bands and a diuse background hybridization, were observed in heart and muscle. The summed intensity of the heart and muscle hybridizing bands was approximately equivalent to the single band observed in brain.
Repeated eorts to raise antisera to Krit1, utilizing both peptide and full-length protein based approaches were unsuccessful, limiting assay of endogenous protein expressing patterns. However, it appear likely that the endogenous Krit1 protein is expressed at low levels in mammalian cells, based on the relatively low (Bork, 1993) , shown at bottom. C, hydrophobic residue. Amino acid position of Krit1 is noted at right. Note, the Krit1 protein sequence identi®es a large number of ankyrin-repeat containing proteins from Genbank; of these, the closest relative is a C. elegans protein whose function is currently unknown (gene ZK265.1, Acc. Z81143; 55% similarity, 30% identity over ankyrin repeats and anking region), followed by the Drosophila protein large Forked (Acc. D21203) and the murine SH3P2 (Acc. U58888) 51 (7) 638 (++++) 2 (+) nd nd nd nd 2 (7) 7 (7) 2 (7) nd nd nd nd 3 (7) A two-hybrid assay was used to map the domain of Krit1 conferring association with Krev-1 and compare interaction of Krit1 and Raf with Krev-1 versus Ras and a negative control, Bicoid. The JG4-5 vector expresses truncated forms of Krit1 or Raf as translational fusions to a transcriptional activation domain. pJK103 was used as a LacZ reporter (2lexAop-LacZ), while EGY48 was used as a LEU2 reporter (6lexAop-LEU2), (Estojak et al., 1995) . Numbers shown re¯ect beta-galactosidase values: ++++, ++, +, and 7 represent relative growth on media lacking leucine. nd, not determined abundance of the Krit1 mRNA, and the fact that its coding sequence contains a high proportion of disfavored codons for amino acid translation (IS and EG, unpublished results). Further, we have experimentally demonstrated that transfection of a plasmid designed to express epitope-tagged Krit1 from the strong CMV promoter into Cos cells, or infection of insect cells with baculovirus expressing Krit1, does not result in detectable levels of protein synthesis even though the Krit 1 mRNA is eciently transcribed, and other similarly transfected controls are well expressed. In contrast, Krit1 protein is expressed well in both yeast (which demonstrate a pattern of codon preference not greatly removed from mammals) and bacteria. At this time we are uncertain as to the source of the limited expression of the Krit1 protein in higher eukaryotes. Finally, in support of the idea that the Krit1 protein is expressed and functional, rather than a disfunctional mRNA, inspection of the dbEST database identi®ed several murine transcripts homologous to Krit1; one typical, AA175084, was 89% identical on the nucleotide level over 450 base pairs, encoding a peptide with 92% identity, 95% similarity to aa 94 ± 243 of Krit 1. This relatively strong conservation pattern suggests the Krit1 protein maintains a cellular function across species.
Chromosomal assignment of Krit1 to 7q21-22
Because of the prior description of Krev-1 as a regulator of oncogenesis, it was of interest to determine whether KRIT1 chromosomal localization suggested a role in cancer. Fluorescence in situ hybridization (FISH) was used for chromosomal assignment of the KRIT1 gene. FISH using a labeled KRIT1 probe spanning the protein coding region revealed speci®c labeling on human chromosome 7 (Figure 4) . Hybridization was detected on chromosome 7 in 33 of 39 metaphase spreads examined. Seventy-®ve of 204 (37%)¯uorescence signals hybridized to the long arm of chromosome 7; all¯uorescent signals on chromosome 7 were located at 7q21-22 often at or near the boundary between these two bands.
Localization of KRIT1 to 7q21-22 is particularly interesting, in that 7q22 has been frequently implicated as a site of chromosomal alterations in a variety of cancers, including myeloid disorders and uterine leiomyomata (Kere et al., 1987; Luna-Fineman et al., 1995; Ogata et al., 1993; Pedersen-Bjergaard et al., 1982; Sargent et al., 1994; Weiss et al., 1987; Yamada et al., 1990) . While a role for Krev-1/rap1A has not been investigated in these classes of malignancies, a characteristic feature of chromosome 7 monosomy and 7q22 deletions is their occurrence as secondary events following hyperactivation of Ras or mutation of the Ras-GAP protein neuro®bromatosis 1 (NF-1) gene (Ballester et al., 1990; Martin et al., 1990; Xu et al., 1990; reviewed in Luna-Fineman et al., 1995) . Insofar as Krev-1 possesses a function as a regulator of Ras activity, or a competitive inhibitor of Ras binding to eectors, deletion of Krit1, a potential positive regulator of Krev-1 activity, may provide an indirect mechanism to enhance Ras-dependent tumor progression.
In summary, we have de®ned a novel partner protein for Krev-1, whose speci®city of interaction, sequence characteristics, and chromosomal location make it an intriguing candidate for further study relative to oncogenesis. Based on its interaction pro®le, it seems likely that this protein may prove to have a function speci®cally related to Krev-1 rather than Ras activity, although this is not yet proven; for example, while both Ras and Krev-1 have been previously shown to bind Ral-GDS, only Ras is able to activate this protein (Urano et al., 1996) . Our current results do not address the cellular function of Krit1. One intriguing possibility, given the frequent association of ankyrin repeat-containing proteins with the cytoskeleton, is that Krit1 may act in localizing the Krev-1 to an appropriate cellular compartment for function. It is hoped that the further characterization of the KRIT1 gene and protein may lead to insights into the ultimate role of Krev-1 in tumor progression and cellular growth control.
Materials and methods
Two-hybrid screen and interaction analysis
Two hybrid screening , interaction mating (Finley and Brent, 1994) , and interaction anity determination (Estojak et al., 1995) were performed as previously described. For library screening, a HeLa library (Gyuris et al., 1993) was probed using LexA-fused to full length Krev-1 as bait, and EGY48 and pJK103 as reporters. For interaction mating, the panel of LexAfused proteins screened included LexA-Max, c-Myc, Cdc2, SSN6, bicoid, daughterless, hairy, CLN3, goosecoid, Cdi1, Cyclin D, Rb, Cdk3, LAR, TR, p53 and others. For analysis of Krit1 truncations, betagalactosidase values were determined for 2 ± 4 independent colonies, with standard deviation from Table 1 values less than 20%; growth on leucine-medium was scored essentially as described in (Estojak et al., 1995) , ranging from ++++ (rapid growth in 1 ± 2 days) to 77 (no detectable growth in 4 or more days).
DNA manipulations
Extension of Krit1 cDNA was performed using a 5'RACEReady cDNA kit from Clontech. The Krit1 cDNA sequence was used to screen expressed sequence tag (EST) databases maintained by the Institute of Genome Research (TIGR) (Consortium, 1995) and Genbank using the BLAST algorithm (Altschul et al., 1990) . Sequence alignments utilized the package of programs available through UWGCG (Devereux et al., 1984) , as well as additional programs as noted in text. The program TSSW, created by VV Solovyev and AA Salamov and located at http://dot.imgen.bcm.tmc.edu:9331/gene-®nder/gf.html, was used to identify promoter elements. To obtain the Krit1 genomic clone, a human genomic library derived from human placental DNA, cloned in the gt11 bacteriophage vector was screened using a 32 P-labeled 1.4 kb fragment of the Krit1 cDNA. Positive clones were detected and puri®ed, subcloned to vector, and sequenced utilizing standard techniques (Ausubel et al., 1987 . The two point mutations in Krit1 1 ± 529** arose spontaneously during PCR subcloning of the full-length cDNA.
Fluorescence in situ hybridization
Normal human metaphase spreads were prepared according to the method of (Fan et al., 1990) . Human lymphocytes were cultured for 72 h at 378C in RPMI 1640 medium containing phytohemagglutinin and 10% fetal bovine serum. Cultures were synchronized by treatment with 5-bromodeoxyuridine (0.18 mg/ml, Sigma) for 16 h, followed by release from the block by incubation in fresh medium containing thymidine (2.5 mg/ml) for 6 h. A KRIT1 cDNA clone was labeled with biotin-16-dUTP by nick translation. Fluorescence in situ hybridization (FISH) and detection of immuno¯uorescence were performed essentially as described previously (Bell et al., 1995) . The chromosome preparations were stained with diamidino-2-phenylindole (DAPI) and observed with a Zeiss Axiophot uorescence microscope. Digitized images were captured with a cooled CCD camera connected to a computer work station. Images of DAPI staining and¯uorescein signals were merged using Oncor Image software, version 1.6.
